ADMA Biologics
ADMA
$6.81
Share price
1.04%
Change (1 day)
99.12%
Change (1 year)
Categories
EPS for ADMA Biologics (ADMA)
EPS in 2023 (TTM): -$0.20
According to ADMA Biologics 's latest financial reports the company's current EPS (TTM) is -$0.20. In 2022 the company made an earnings per share (EPS) of -$0.34 an increase over its 2021 EPS that were of -$0.53.
EPS history for ADMA Biologics from 2010 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.20 | -41.18% |
| 2022 | -$0.34 | -35.85% |
| 2021 | -$0.53 | -39.77% |
| 2020 | -$0.88 | -2.22% |
| 2019 | -$0.90 | -38.36% |
| 2018 | -$1.46 | -24.61% |
| 2017 | -$1.94 | 19.54% |
| 2016 | -$1.62 | -6.9% |
| 2015 | -$1.74 | -3.87% |
| 2014 | -$1.81 | -23.95% |
| 2013 | -$2.38 | 80.3% |
| 2012 | -$1.32 | |
| 2011 | N/A | |
| 2010 | N/A |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | $2.09 | -1,145.00% | 🇺🇸 USA |
 Novavax NVAX | -$7.19 | 3,495.00% | 🇺🇸 USA |
 Cel-Sci
CVM | -$0.77 | 285.00% | 🇺🇸 USA |